Suboxone and the Opioid Debate

This chapter explores the controversial dynamics of Suboxone prescriptions following the Mainstream Addiction Treatment Act, discussing its potential impact on opioid-related deaths and quality of life. It critiques the financial ties between researchers and the pharmaceutical industry, questioning the motivations behind addiction treatment options and highlighting alternative therapies like Ibogaine.